EDGAR Filing Documents for 0001662252-18-000050

Form 8-K - Current report:

SEC Accession No. 0001662252-18-000050

Filing Date

2018-03-23

Accepted

2018-03-23 17:21:16

Documents

Period of Report

2018-03-15

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	rcha8k.htm	8-K	28595
2	EX-10.73	ex10_73.htm	EX-10.73	182940
3	EX-10.74	ex10_74.htm	EX-10.74	273489
	Complete submission text file	0001662252-18-000050.txt		486261

Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212

Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001

Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54767 | Film No.: 18711086
SIC: 2834 Pharmaceutical Preparations